EP2744517 - COMPOSITIONS AND METHODS RELATED TO ANTIBODIES TO STAPHYLOCOCCAL PROTEIN A [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.01.2020 Database last updated on 16.11.2024 | |
Former | The patent has been granted Status updated on 08.02.2019 | ||
Former | Grant of patent is intended Status updated on 09.10.2018 | ||
Former | Examination is in progress Status updated on 11.01.2017 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states The University of Chicago 5801 South Ellis Avenue Chicago, IL 60637 / US | [2014/26] | Inventor(s) | 01 /
SCHNEEWIND, Olaf c/o The University of Chicago 5801 S. Ellis Ave. Chicago, IL 60637 / US | 02 /
MISSIAKAS, Dominique, M. c/o The University of Chicago 5801 S. Ellis Ave. Chicago, IL 60637 / US | 03 /
KIM, Hwan, Keun c/o The University of Chicago 5801 S. Ellis Ave. Chicago, IL 60637 / US | 04 /
EMOLO, Carla c/o The University of Chicago 5801 S. Ellis Ave. Chicago, IL 60637 / US | 05 /
DEDENT, Andrea c/o The University of Chicago 5801 S. Ellis Ave. Chicago, IL 60637 / US | [2014/30] |
Former [2014/26] | 01 /
SCHNEEWIND, Olaf 5628 S. Blackstone Ave. Chicago, IL 60637 / US | ||
02 /
MISSIAKAS, Dominique, M. 5628 S. Blackstone Ave. Chicago, IL 60637 / US | |||
03 /
KIM, Hwan, Keun 906 East 53rd Apt. 1 Chicago, IL 60615 / US | |||
04 /
EMOLO, Carla c/o The University of Chicago 5801 S. Ellis Chicago, IL 60637 / US | |||
05 /
DEDENT, Andrea c/o The University of Chicago 5801 S. Ellis Chicago, IL 60637 / US | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2019/11] | J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
Former [2014/26] | Roberts, Joanne Nicola J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 12823843.3 | 15.08.2012 | [2019/11] | WO2012US50991 | Priority number, date | US201161523751P | 15.08.2011 Original published format: US 201161523751 P | US201261615083P | 23.03.2012 Original published format: US 201261615083 P | US201261618417P | 30.03.2012 Original published format: US 201261618417 P | US201261674135P | 20.07.2012 Original published format: US 201261674135 P | [2014/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2013025834 | Date: | 21.02.2013 | Language: | EN | [2013/08] | Type: | A2 Application without search report | No.: | EP2744517 | Date: | 25.06.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.02.2013 takes the place of the publication of the European patent application. | [2014/26] | Type: | B1 Patent specification | No.: | EP2744517 | Date: | 13.03.2019 | Language: | EN | [2019/11] | Search report(s) | International search report - published on: | KR | 25.04.2013 | (Supplementary) European search report - dispatched on: | EP | 19.03.2015 | Classification | IPC: | A61K39/395, A61K48/00, A61P31/00, A61P37/00, C07K16/12, A61K45/06 | [2015/16] | CPC: |
C07K16/1271 (EP,US);
A61J1/00 (US);
A61K39/40 (US);
A61K45/06 (EP,US);
A61P31/00 (EP);
A61P31/04 (EP);
A61P37/00 (EP);
C07K16/4233 (EP,US);
G01N33/6854 (US);
A61K2039/505 (EP,US);
A61K2039/507 (EP,US);
A61K2039/545 (US);
A61K38/00 (EP,US);
A61K39/085 (US);
C07K2317/14 (US);
C07K2317/21 (US);
C07K2317/51 (US);
C07K2317/515 (US);
C07K2317/56 (US);
C07K2317/565 (US);
C07K2317/569 (US);
C07K2317/76 (EP,US);
C07K2317/92 (EP,US);
G01N2333/31 (US);
G01N2500/04 (US)
(-)
| C-Set: |
A61K39/395, A61K2300/00 (EP)
|
Former IPC [2014/26] | A61K39/395, A61K48/00, A61P31/00, A61P37/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/26] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN IN ZUSAMMENHANG MIT ANTIKÖRPERN GEGEN DAS STAPHYLOKOKKEN-PROTEIN A | [2014/26] | English: | COMPOSITIONS AND METHODS RELATED TO ANTIBODIES TO STAPHYLOCOCCAL PROTEIN A | [2014/26] | French: | COMPOSITIONS ET PROCÉDÉS LIÉS AUX ANTICORPS ANTI-PROTÉINE A DU STAPHYLOCOQUE | [2014/26] | Entry into regional phase | 05.03.2014 | National basic fee paid | 05.03.2014 | Search fee paid | 05.03.2014 | Designation fee(s) paid | 05.03.2014 | Examination fee paid | Examination procedure | 05.03.2014 | Examination requested [2014/26] | 06.10.2015 | Amendment by applicant (claims and/or description) | 15.09.2016 | Despatch of a communication from the examining division (Time limit: M06) | 27.03.2017 | Reply to a communication from the examining division | 12.04.2017 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.2017 | Reply to a communication from the examining division | 13.11.2017 | Despatch of a communication from the examining division (Time limit: M06) | 09.05.2018 | Reply to a communication from the examining division | 15.06.2018 | Despatch of a communication from the examining division (Time limit: M02) | 22.08.2018 | Reply to a communication from the examining division | 10.10.2018 | Communication of intention to grant the patent | 01.02.2019 | Fee for grant paid | 01.02.2019 | Fee for publishing/printing paid | 01.02.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.09.2016 | Opposition(s) | 16.12.2019 | No opposition filed within time limit [2020/08] | Fees paid | Renewal fee | 13.08.2014 | Renewal fee patent year 03 | 25.08.2015 | Renewal fee patent year 04 | 11.08.2016 | Renewal fee patent year 05 | 14.08.2017 | Renewal fee patent year 06 | 28.08.2018 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 15.08.2012 | AL | 13.03.2019 | AT | 13.03.2019 | CY | 13.03.2019 | CZ | 13.03.2019 | DK | 13.03.2019 | EE | 13.03.2019 | ES | 13.03.2019 | FI | 13.03.2019 | HR | 13.03.2019 | IT | 13.03.2019 | LT | 13.03.2019 | LV | 13.03.2019 | MC | 13.03.2019 | MK | 13.03.2019 | MT | 13.03.2019 | NL | 13.03.2019 | PL | 13.03.2019 | RO | 13.03.2019 | RS | 13.03.2019 | SE | 13.03.2019 | SI | 13.03.2019 | SK | 13.03.2019 | SM | 13.03.2019 | TR | 13.03.2019 | BG | 13.06.2019 | NO | 13.06.2019 | GR | 14.06.2019 | IS | 13.07.2019 | PT | 13.07.2019 | GB | 15.08.2019 | IE | 15.08.2019 | LU | 15.08.2019 | BE | 31.08.2019 | CH | 31.08.2019 | LI | 31.08.2019 | [2022/31] |
Former [2021/34] | HU | 15.08.2012 | |
AL | 13.03.2019 | ||
AT | 13.03.2019 | ||
CY | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
MC | 13.03.2019 | ||
MT | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
TR | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
GB | 15.08.2019 | ||
IE | 15.08.2019 | ||
LU | 15.08.2019 | ||
BE | 31.08.2019 | ||
CH | 31.08.2019 | ||
LI | 31.08.2019 | ||
Former [2021/33] | HU | 15.08.2012 | |
AL | 13.03.2019 | ||
AT | 13.03.2019 | ||
CY | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
MC | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
TR | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
GB | 15.08.2019 | ||
IE | 15.08.2019 | ||
LU | 15.08.2019 | ||
BE | 31.08.2019 | ||
CH | 31.08.2019 | ||
LI | 31.08.2019 | ||
Former [2021/26] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CY | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
MC | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
TR | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
GB | 15.08.2019 | ||
IE | 15.08.2019 | ||
LU | 15.08.2019 | ||
BE | 31.08.2019 | ||
CH | 31.08.2019 | ||
LI | 31.08.2019 | ||
Former [2020/37] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
MC | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
TR | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
GB | 15.08.2019 | ||
IE | 15.08.2019 | ||
LU | 15.08.2019 | ||
BE | 31.08.2019 | ||
CH | 31.08.2019 | ||
LI | 31.08.2019 | ||
Former [2020/36] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
MC | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
TR | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
IE | 15.08.2019 | ||
LU | 15.08.2019 | ||
CH | 31.08.2019 | ||
LI | 31.08.2019 | ||
Former [2020/25] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
MC | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
TR | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
LU | 15.08.2019 | ||
CH | 31.08.2019 | ||
LI | 31.08.2019 | ||
Former [2020/17] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
TR | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
Former [2020/13] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SI | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
Former [2020/09] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
DK | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
Former [2020/04] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
IS | 13.07.2019 | ||
PT | 13.07.2019 | ||
Former [2020/03] | AL | 13.03.2019 | |
AT | 13.03.2019 | ||
CZ | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
PT | 13.07.2019 | ||
Former [2019/52] | AL | 13.03.2019 | |
CZ | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
PL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SK | 13.03.2019 | ||
SM | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
PT | 13.07.2019 | ||
Former [2019/49] | AL | 13.03.2019 | |
CZ | 13.03.2019 | ||
EE | 13.03.2019 | ||
ES | 13.03.2019 | ||
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
RO | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
SK | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
PT | 13.07.2019 | ||
Former [2019/48] | ES | 13.03.2019 | |
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
PT | 13.07.2019 | ||
Former [2019/47] | ES | 13.03.2019 | |
FI | 13.03.2019 | ||
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
Former [2019/46] | FI | 13.03.2019 | |
HR | 13.03.2019 | ||
IT | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
Former [2019/39] | FI | 13.03.2019 | |
HR | 13.03.2019 | ||
LT | 13.03.2019 | ||
LV | 13.03.2019 | ||
NL | 13.03.2019 | ||
RS | 13.03.2019 | ||
SE | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
Former [2019/38] | FI | 13.03.2019 | |
LT | 13.03.2019 | ||
SE | 13.03.2019 | ||
BG | 13.06.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
Former [2019/37] | FI | 13.03.2019 | |
LT | 13.03.2019 | ||
SE | 13.03.2019 | ||
NO | 13.06.2019 | ||
GR | 14.06.2019 | ||
Former [2019/34] | FI | 13.03.2019 | |
LT | 13.03.2019 | ||
SE | 13.03.2019 | ||
NO | 13.06.2019 | ||
Former [2019/33] | FI | 13.03.2019 | |
LT | 13.03.2019 | ||
NO | 13.06.2019 | Documents cited: | Search | [XDI]WO2011005341 (UNIV CHICAGO [US], et al) [XD] 1,2,4-6,8 * example 2 * [I] 3,7,15; | [AD]US2008118937 (MACH PATRICK A [US]) [AD] 1-15 * example - * * claim - *; | [A]WO2008140487 (ELUSYS THERAPEUTICS INC [US], et al) [A] 1-15 * example - * | [XDI] - H. KIM ET AL., "Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.", THE JOURNAL OF EXPERIMENTAL MEDICINE, (20100830), vol. 207, no. 9, pages 1863 - 1870, XP002737099 [XD] 1,2,4-6,8 * the whole document * [I] 3,7,15 DOI: http://dx.doi.org/10.1084/jem.20092514 | International search | [A]US2006205016 (SILVERMAN GREGG J [US]); | [A]US2006246083 (DALE JAMES B [US]); | [A]US2010063256 (SPECTOR SHARI [US]); | [A]US2011002932 (PIER GERALD B [US], et al); | [X]WO2011005341 (UNIV CHICAGO [US], et al); | [A]US2011117099 (ARRECUBIETA CARLOS [US], et al); | Examination | - ROLAND REPP ET AL, "Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 373, no. 1, doi:10.1016/J.JIM.2011.08.003, ISSN 0022-1759, (20110803), pages 67 - 78, (20110809), XP028318674 DOI: http://dx.doi.org/10.1016/j.jim.2011.08.003 | by applicant | US3817837 | US3850752 | US3939350 | US3996345 | US4196265 | US4275149 | US4277437 | US4338298 | US4366241 | US4472509 | US4554101 | EP0216846 | US4684611 | EP0256055 | US4748018 | EP0323997 | EP0338841 | US4879236 | US4938948 | US4952500 | US5021236 | US5196066 | WO9311161 | US5262357 | US5302523 | US5310687 | WO9409699 | US5322783 | WO9413804 | US5384253 | WO9506128 | US5464765 | US5505928 | US5512282 | US5538877 | US5538880 | US5548066 | US5550318 | US5563055 | US5580859 | US5589466 | US5591616 | US5610042 | US5648240 | US5656610 | US5690807 | US5702932 | US5736524 | US5741957 | US5750172 | US5756687 | US5780448 | US5789215 | US5801234 | US5827690 | US5840846 | WO9857994 | US5871986 | WO9926299 | US5945100 | US5981274 | US5990479 | US5994624 | US6008341 | WO0002523 | WO0012132 | WO0012689 | WO0015238 | US6048616 | US6091001 | US6274323 | WO0160852 | US6288214 | US2002169288 | US6630307 | US6651655 | US6756361 | US6770278 | US6793923 | US2005106660 | US6936258 | US2006058510 | WO2006032472 | WO2006032475 | WO2006032500 | US2006088908 | WO2006056464 | WO2007113222 | WO2007113223 | US2008118937 | US2010047252 | US2010285564 | WO2011005341 | WO2012003474 | US20090170779 | US20090103196 | US20090166432 |